Giving Tuesday is Tomorrow! Together We Give!

Giving Tuesday

This has been a difficult year for everyone—especially those who are experiencing isolation due to COVID-19. Many people are desperate for connection, and we try to share resources to encourage the ASIP spirit during these challenging times. The pandemic continues to take a toll on health care workers.


There is hope, and you can help.
We want to continue our efforts in discovering disease mechanisms with even more ways to support education in pathology. We would love to have you join us for #GivingTuesday. 
ASIP joined #GivingTuesday last year and raised funds for travel awards. This year our goal is to raise $10,000. Your donations will be matched by the ASIP!


How can you help?

As a supporter of the ASIP, we need your help. Please share our fundraiser with your network on #GivingTuesday. We welcome any donation amount. Mark your calendar and help us reach our $10,000 goal. 
How will the money raised be used?

This year, the ASIP is fundraising to provide support for undergraduate to work in a research laboratory during summer 2021 through the ASIP Summer Research Opportunity Program in Pathology (SROPP). This program promotes the entry of young scientists into the mainstream of the basic, translational, and clinical research communities and provides summer research opportunities in pathobiology mentored by ASIP members. Donations can also be designated towards the Pathology Leadership Fund, any of our named Trainee Scholar Awards, or any of our named Junior Faculty Scholar Awards.


Why Give?

Your Impact has helped many past award recipients. Will you consider donating this year to ASIP to help advance pathology education?
Every $ raised is helpful. Thank you for your support. Click the red button below to donate. We are grateful for you and your generosity. Together, we can make lasting change.

Women in Pathology Giving Tuesday Fundraiser on Facebook

Log in or sign up to view

See posts, photos and more on Facebook.

About #GivingTuesday

Abstract and Registration Site for #ASIP2022 at #ExpBio is OPEN until Nov 30!

ASIP Annual Meeting at Experimental Biology

Don’t miss the last ASIP Annual meeting at Experimental Biology as we meet in person in Philadelphia. This year’s theme is, “Basic Science and Translational Research into Mechanisms of Human Disease – Improving Disease Prevention, Detection, Diagnosis, and Treatment.” Become an important part of this cutting-edge meeting as you can reconnect with colleagues, and meet new scientists who provide outstanding research and cutting-edge advances in the life sciences field. There is a place for your science with our variety of topic categories! Determine your abstract topic and submit your abstract for an oral or poster presentation.

An exciting lineup of basic and translational research talks presented by well-known senior and up-and-coming junior scientists and trainees has been organized by the ASIP 2022 Program Committee in collaboration with our membership, Scientific Interest Groups, and guest societies Importantly, ASIP Trainee members (including undergraduate students) and Junior Faculty who submit abstracts to ASIP Topic Categories are eligible to be considered for travel awards. Please see the details about the many special award opportunities here.

Submit your abstract to be eligible for these awards, including scholar awards for trainees and junior faculty which will cover registration costs.

Your safety is our top priority. Vaccinations will be required.

#ASIP2022 at #ExpBio

  • Lectures
  • Symposia
  • Workshops
  • Special Sessions & More!



  • Abstract Deadline: November 30
Experimental Biology 2022
Register Now

Register soon for the best rates.

Not a Member? Save on registration when you join the ASIP!

 NOW is the time to join so you can receive discounted registration rates

AND the many benefits that come with membership.

Learn more

Pathobiology Course for Research Scientists: Cell Death and Inflammation in Health and Disease

Pathobiology Course for Research Scientists: Cell Death and Inflammation in Health and Disease

Sponsored by the ASIP Education Committee

Session Description:  Unresolved inflammation is a major mechanism of pathogenesis in many human diseases. A paradigm shift is emerging in our understanding of the pathogenesis of inflammation which results not only from persistent activation of inflammatory signals, but also from the active loss of pro-resolution mechanisms. Differentiating between the suppression and resolution of inflammation driven by pro-resolution mediators is critical for the treatment of various inflammatory diseases.

Dipak Panigrahy, MD

Chair
Dipak Panigrahy, MD
Beth Israel Deaconess Medical Center Harvard Medical School


Christopher D. Gregory, PhD

Pro-oncogenic Potential of Apoptotic Cells in the Tumor Microenvironment

Christopher D. Gregory, PhD
University of Edinburgh Centre for Inflammation Research
Queen’s Medical Research Institute Edinburgh, UK

Sergei Grivennikov, PhD

Microbes, Tumor-elicited Inflammation and Cancer

Sergei Grivennikov, PhD
Samuel Oschin Comprehensive Cancer Institute
Cedars-Sinai Medical Center, Los Angeles, CA


Ann C. Skulas-Ray, PhD

Inflammation in Health and Disease

Ann C. Skulas-Ray, PhD
Department of Nutritional Sciences
School of Nutritional Sciences and Wellness
The University of Arizona
College of Agriculture and Life Sciences Tuscon, AZ

Selvakumar Subbian, PhD

Inflammation and Cell Death in Tuberculosis

Selvakumar Subbian, PhD
Public Health Research Institute
New Jersey Medical School
Rutgers University Newark, NJ


Experimental Biology 2022
Submit an Abstract
Register Now

Register soon for the best rates.
Not a Member? Save on registration when you join the ASIP!
 NOW is the time to join so you can receive discounted registration rates
AND the many benefits that come with membership.
Learn more

Abstract Deadline: November 30

Apply for Travel Awards TODAY!

#ASIP2022 at #ExpBio

Dr. Cecelia Yates Receives the Emerging Innovator Award from the University of Pittsburgh

Yates
Yates

Congratulations to Dr. Cecelia Yates for receiving the Emerging Innovator Award from the University of Pittsburgh Innovation Institute. The Innovation Institute established the Emerging Innovator Award in recognition of the potential difference developers can make on people’s lives through commercial translation. The Emerging Innovator Award was established three years ago to recognize Pitt innovators in mid-career who have demonstrated an extraordinary commitment to achieving impact for their research through commercialization.

Dr. Yates is an Associate Professor in the Department of Health Promotion & Development, School of Nursing at the University of Pittsburgh, with secondary appointments in the Department of Pathology, School of Medicine, and the Department of Bioengineering, School of Engineering.  Additionally, she is co-director of the University of Pittsburgh’s Clinical and Translational Science Institute’s TL1 Predoctoral Fellowship sponsored by NIH Clinical and Translational Science Awards (CTSA) Program. Dr. Yates attended Tuskegee University, Tuskegee, Alabama, where she earned her BS in Biology/Chemistry and her PhD in Integrative Biomedical Science and Pathology in conjunction with the University of Pittsburgh. Upon completing her education, she participated in a Fellowship in Pathology at Pitt’s School of Medicine.

She is the co-founder and Chief Scientific Officer of Fibrokine Inc., a Pittsburgh-based start-up developing a broad spectrum of anti‐fibrotic chemokine peptides to treat organ fibrosis. She is also the co-founder and member of the Scientific Advisory Board of a Pittsburgh-based start-up, Ocugenix, focused on ocular therapeutic development. In addition, she is involved with several ongoing therapeutic commercialization ventures.

Dr. Yates has over 15 years of experience in fibroblast, chemokine, and extracellular matrix biology and the pathogenesis of organ fibrosis. She has a continuous track record of innovative research and therapeutic development in the field of tissue repair. Her research focuses are on understanding immune cell and stromal cell mediated interactions that contribute to the pathogenesis of fibrotic diseases such as systemic sclerosis (Scleroderma) and IPF. Her research group combines both translational and clinical models to develop therapeutics including biometric peptides, cellular transplantation, and bioreactive scaffolds to promote tissue regeneration. Dr. Yates’ research has been supported externally by the National Institute of Nursing Research, National Institute of General Medical Sciences, National Institute of Arthritis and Musculoskeletal and Skin Diseases, and internally by the Chancellor’s Innovation Award, the Center for Medical Innovation, and the University of Pittsburgh Genomic Hub. Dr. Yates’ entrepreneurial activities include more than eight issued US patents, several international patents, and pending applications associated with her work.

Dr. Yates received the 2011 ASIP Excellence in Science Award and serves on the ASIP Council in the role of Councilor At-large. She is a member of a number of ASIP Committees, including the Research and Science Policy Committee and the Membership Committee. Dr. Yates serves as a member of the Editorial Board for The American Journal of Pathology

Congratulations, Dr. Yates!

Women in Pathology Leadership Development Event!

Deb Elbaum

Confident leadership requires time and self-reflection about one’s current strengths, as well as areas for development. Putting energy and intention toward developing these areas can help us not only build our authentic leadership presence and voice, but also result in greater interpersonal effectiveness and impact. In this interactive 1-hour workshop with Leadership Coach Deb Elbaum, attendees will get clearer about their current leadership skills and identify where they can put attention to be even more successful in their current or future role.

Deb Elbaum is an executive and leadership development coach who has been guiding people to think and act calmly and confidently for more than 15 years. She builds her clients’ capacity to manage challenges more effectively – including navigating change, building teams, creating strategic plans, communicating successfully, and inspiring and engaging others. Deb’s approach to coaching combines neuroscience, leadership models, and measurable action planning. She equips her clients for success by building their internal awareness and strategy toolkit so that they can quickly increase their external impact, interpersonal effectiveness, and authentic leadership presence.

A former physician and founder of a healthcare writing company, Deb partners with senior and emerging leaders in academia, healthcare, biotech, and pharma. Examples of clients include MIT, Tufts University, St. Jude Children’s Research Hospital, Massachusetts General Hospital, Takeda, Sanofi, and Karyopharm Therapeutics. Deb is known for her positive energy and ability to carefully listen, quickly reframe, and hone in on the heart of the matter. Her clients learn how to identify blindspots that are holding them back, cultivate their authentic leadership, and shift behaviors so they feel more purposeful, balanced, and productive.